Cite
HARVARD Citation
Cheng, C. et al. (2018). EGFR-mediated interleukin enhancer-binding factor 3 contributes to formation and survival of cancer stem-like tumorspheres as a therapeutic target against EGFR-positive non-small cell lung cancer. Lung cancer. pp. 80-89. [Online].